J&J faces $2bn insurance fraud charges over opioid claims
The New York State Department of Financial Services (DFS) has filed a $2bn lawsuit against Johnson & Johnson (J&J) for…
18 Sep 2020
BioNTech to acquire Novartis site for Covid-19 vaccine production
BioNTech has signed a share purchase agreement with Novartis to acquire a manufacturing site to boost its messenger RNA (mRNA)-based BNT162 Covid-19 vaccine candidate production capacity. Expected to be fully…
18 Sep 2020
Lilly partners with Amgen to manufacture Covid-19 antibody therapies
Eli Lilly has formed a global antibody manufacturing partnership with Amgen to boost the supply capacity for its therapy candidates against Covid-19. Currently, Lilly is testing various neutralising antibodies, as…
17 Sep 2020
Palleon Pharmaceuticals secures $100m in Series B funding
Palleon Pharmaceuticals has raised $100m in a Series B financing round to develop drugs targeting glycan-mediated immune regulation to treat cancer and inflammatory diseases. The financing round, led by Matrix…
17 Sep 2020
AstraZeneca acquires Dogma Therapeutics’ PCSK9 inhibitor programme
AstraZeneca has signed an agreement to purchase a preclinical oral PCSK9 inhibitor programme from Dogma Therapeutics for an undisclosed amount. PCSK9 is a protein that modulates the low-density lipoprotein (LDL)…
17 Sep 2020
Moderna and Vertex partner on gene-editing therapies for cystic fibrosis
Moderna has teamed up with Vertex Pharmaceuticals to identify and develop lipid nanoparticles (LNPs) and messenger RNAs (mRNAs) for the delivery of gene-editing therapies to treat cystic fibrosis (CF). Under…
16 Sep 2020
India’s Dr Reddy’s signs deal for Russia’s Sputnik V Covid-19 vaccine
India-based pharmaceutical company Dr Reddy’s Laboratories has partnered with the Russian Direct Investment Fund (RDIF) for clinical trials and supply of Sputnik V Covid-19 vaccine. After obtaining regulatory approval in…